Divergent H7 immunogens offer protection from H7N9 virus challenge. - Wikidata - awgldk - TriplyDB

Divergent H7 immunogens offer protection from H7N9 virus challenge.

Divergent H7 immunogens offer protection from H7N9 virus challenge.

http://www.wikidata.org/entity/Q30358196

about

Airborne transmission of highly pathogenic H7N1 influenza virus in ferrets Mammalian Pathogenesis and Transmission of H7N9 Influenza Viruses from Three Waves, 2013-2015 Tackling a novel lethal virus: a focus on H7N9 vaccine development.H7N9 Live Attenuated Influenza Vaccine Is Highly Immunogenic, Prevents Virus Replication, and Protects Against Severe Bronchopneumonia in Ferrets.Zoonotic infections with avian influenza A viruses and vaccine preparedness: a game of "mix and match"Considerations for the rapid deployment of vaccines against H7N9 influenza.Preexisting human antibodies neutralize recently emerged H7N9 influenza strains.Immunization with a live attenuated H7N9 influenza vaccine protects mice against lethal challenge.Prevention of Influenza A(H7N9) and Bacterial Infections in Mice Using Intranasal Immunization With Live Influenza Vaccine and the Group B Streptococcus Recombinant Polypeptides.Development of a high-yield live attenuated H7N9 influenza virus vaccine that provides protection against homologous and heterologous H7 wild-type viruses in ferrets An H7N1 influenza virus vaccine induces broadly reactive antibody responses against H7N9 in humans.A single immunization with modified vaccinia virus Ankara-based influenza virus H7 vaccine affords protection in the influenza A(H7N9) pneumonia ferret model.Newcastle Disease Virus-Vectored H7 and H5 Live Vaccines Protect Chickens from Challenge with H7N9 or H5N1 Avian Influenza Viruses.Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses.Generation and Characterization of Live Attenuated Influenza A(H7N9) Candidate Vaccine Virus Based on Russian Donor of Attenuation.New England harbor seal H3N8 influenza virus retains avian-like receptor specificity.Broadly-Reactive Neutralizing and Non-neutralizing Antibodies Directed against the H7 Influenza Virus Hemagglutinin Reveal Divergent Mechanisms of Protection Recombinant H7 hemagglutinin forms subviral particles that protect mice and ferrets from challenge with H7N9 influenza virus Impact of Adjuvants on the Immunogenicity and Efficacy of Split-Virion H7N9 Vaccine in Ferrets.Cross-reactivity between avian influenza A (H7N9) virus and divergent H7 subtypic- and heterosubtypic influenza A viruses Characterization of Influenza Vaccine Hemagglutinin Complexes by Cryo-Electron Microscopy and Image Analyses Reveals Structural Polymorphisms Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection Influenza A Viruses Expressing Intra- or Intergroup Chimeric Hemagglutinins.Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes.Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.Novel Bivalent Viral-Vectored Vaccines Induce Potent Humoral and Cellular Immune Responses Conferring Protection against Stringent Influenza A Virus Challenge.An H10N8 influenza virus vaccine strain and mouse challenge model based on the human isolate A/Jiangxi-Donghu/346/13.Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans.Two genetically diverse H7N7 avian influenza viruses isolated from migratory birds in central China.Cross-reactive mouse monoclonal antibodies raised against the hemagglutinin of A/Shanghai/1/2013 (H7N9) protect against novel H7 virus isolates in the mouse model.Characterization of Hemagglutinin Antigens on Influenza Virus and within Vaccines Using Electron Microscopy.

P2860

Q28387714-0656A710-1D7A-4A4D-B94E-36A70D9BCBA1 Q28392524-163841C1-69C3-441A-905A-A631FE8F9A4B Q30148631-CC952006-A0A0-41F3-B3C4-49BBA18AAD39 Q30196901-C330C2AA-A33F-44C3-8344-897F854FF890 Q30209434-144BEADE-D216-4096-80BE-98FF937670A0 Q30364635-35A459BE-E869-4DF8-B135-6F9138F4EACF Q30371836-A5F6306A-8B5E-4958-9620-42765B3F7A1D Q30373843-E4BA8605-8CEC-4F37-A8E9-E02B7B8518A7 Q30403077-E4002AC9-CA1E-45CA-8431-3605CC86B46A Q33743763-EE6FA19D-4BEA-4565-9BBC-A878289AA64D Q34057737-B1098135-A58F-4CCC-AD50-A5BCAA75A81E Q35474243-70BFD290-611B-46AD-8A65-4B535F5EDE98 Q35618503-77B59E51-6FD8-489C-A2B6-C3B1DA240162 Q35756765-58E9F81A-C41F-4DBF-B544-7F8526BDF692 Q35787563-73590781-FBD9-48D7-8E50-AAA38E3A7DDB Q35926768-70066811-B733-4A20-BABB-67EC62B7391A Q35990859-B77D2410-D12D-4789-99AB-E5DCE5BD5769 Q36037316-D8234D7E-8FD8-497F-904C-3E642B275E06 Q36139178-2E75BF1C-493A-4830-9D8A-B15346C6D488 Q36611283-00FF3C89-943F-44F9-B093-126B7DEFF161 Q36973969-10ECB3D7-E788-48C8-8075-980E0370EC20 Q36991414-03DD0F4D-FE76-4713-9FD4-0E74D1BD4C36 Q38803889-686B41BD-0969-492A-AD6B-2097FE32E0BF Q40075978-5E86D252-55F4-47DE-9EBE-F2AF6083F5C7 Q40097582-1C50B2F1-511D-4D2D-AEE5-8115776D23E5 Q40116170-ECA02353-7902-4929-8299-8E96FD8B0F49 Q41531938-0194B70D-14CC-4317-A35B-341B98DB47DC Q47137425-E8BCB771-BF84-42E0-8C75-D9480430DB0F Q52595414-0AE63DFC-6480-4AA6-9D2D-A0306FF22E40 Q55260817-CE992295-9D5C-4345-9A3B-A00DA4EA0EE6 Q55689231-9BAB0CD4-05DC-4492-B8B2-522559606AC2

P2860

Divergent H7 immunogens offer protection from H7N9 virus challenge.

http://www.wikidata.org/entity/Q30358196

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Divergent H7 immunogens offer protection from H7N9 virus challenge.

@ast

Divergent H7 immunogens offer protection from H7N9 virus challenge.

@en

type

label

Divergent H7 immunogens offer protection from H7N9 virus challenge.

@ast

Divergent H7 immunogens offer protection from H7N9 virus challenge.

@en

prefLabel

Divergent H7 immunogens offer protection from H7N9 virus challenge.

@ast

Divergent H7 immunogens offer protection from H7N9 virus challenge.

@en

P1433

Q30358196-3B441769-AFFD-4896-A2D3-CC21D199E5FA

P1476

Q30358196-8FA46DB3-9ECC-4C56-A7C0-E45327BAF45D

P2093

Q30358196-5F9BAC29-65E8-416B-8CD5-DF82D515C1C9

Q30358196-73384B04-FBE2-4A5E-9842-F91AA71FC4B1

Q30358196-7A3055C4-2299-4B37-8549-B5B225311F0E

Q30358196-9BC3EA8D-57F5-41A6-BB84-414288B4ED06

Q30358196-CA9F91F8-86B6-4C43-9FC4-54663050A24A

Q30358196-CD986E37-F1C3-4601-84F3-EC1B5533F946

Q30358196-DFCD56B5-7BFB-4ACD-B659-DC8CD1FB4851

P2860

Q30358196-00E6BC84-B9ED-413F-9F70-31E6C975BA4A

Q30358196-065A004D-E3F8-4250-918F-EB8414DC2EE3

Q30358196-0E437BA9-701C-48B4-9F19-995945AB62E9

Q30358196-10E67A46-4AEA-41FD-A9C3-F7B36E24C822

Q30358196-1C312AD4-0AF1-47DC-AC37-175FF2814976

Q30358196-1DC6CEEC-C6EF-437E-8FFF-760800EF68BB

Q30358196-318AF7AE-284A-446B-AF79-DF837268103F

Q30358196-3235FF2E-DB98-4B52-BDE8-ED39B1853C34

Q30358196-3605ACBD-1B7E-47CE-8973-16D507314418

Q30358196-366BFDCF-90E4-4C27-B230-0199E85BF803

P304

Q30358196-A2D08A22-F731-403F-ACA9-ABD417BDF260

P31

Q30358196-6E96FA44-3CEA-486B-9A39-E4A5D545F745

P356

Q30358196-E1FF78FA-C9EF-4D55-A90E-2781A2269D26

P433

Q30358196-7E6C364D-8C0B-41A1-AF11-1BBB7483BC67

P478

Q30358196-50663E38-0D46-47AF-A529-03F0B3B00390

P50

Q30358196-5AF7DA4D-E582-4B99-9CA8-97393D5CD3AE

Q30358196-62D24BEC-DA7C-4003-A983-2B5F3E915CFE

Q30358196-738D60CC-BBCB-4478-A71F-4E4BCD271362

Q30358196-7CCC4867-7A00-45A5-BBBB-6D558D6A9AA6

Q30358196-89C14678-C1C6-4B37-A494-2E0A1D8A1C1C

Q30358196-8DBFF259-4062-4F7D-89BB-1E7D6D66FD44

P577

Q30358196-23CA2087-8F49-40C9-A0B8-1E9DDC013666

P698

Q30358196-E126BD43-7456-4DAE-A3DA-335894225577

P932

Q30358196-7573C362-C621-4821-80F9-E7AE6E2EB4E0

P356

P1433

Journal of Virology

P1476

Divergent H7 immunogens offer protection from H7N9 virus challenge.

@en

P2093

Irina Margine

http://www.w3.org/2001/XMLSchema#string

John J Treanor

http://www.w3.org/2001/XMLSchema#string

Jonathan Runstadler

http://www.w3.org/2001/XMLSchema#string

Mirco Schmolke

http://www.w3.org/2001/XMLSchema#string

Patrick C Wilson

http://www.w3.org/2001/XMLSchema#string

Rong Hai

http://www.w3.org/2001/XMLSchema#string

Sarah F Andrews

http://www.w3.org/2001/XMLSchema#string

P2860

Human illness from avian influenza H7N3, British Columbia

Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome

H7N9 avian influenza A virus and the perpetual challenge of potential human pandemicity

Highly Conserved Protective Epitopes on Influenza B Viruses

Preferential Recognition of Avian-Like Receptors in Human Influenza A H7N9 Viruses

Receptor binding by an H7N9 influenza virus from humans

Human infection with a novel avian-origin influenza A (H7N9) virus

Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance.

A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine.

Characterization of H7N9 influenza A viruses isolated from humans.

P304

3976-3985

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.03095-13

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P50

Adolfo García-Sastre

Florian Krammer

Randy A. Albrecht

P577

2014-01-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24453375

http://www.w3.org/2001/XMLSchema#string

P932

3993735

http://www.w3.org/2001/XMLSchema#string